

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.16729540 |
| 2 | sarcomere organization (GO:0045214) | 5.99829242 |
| 3 | carnitine shuttle (GO:0006853) | 5.82353110 |
| 4 | myofibril assembly (GO:0030239) | 5.73752296 |
| 5 | cardiac myofibril assembly (GO:0055003) | 5.67030851 |
| 6 | creatine metabolic process (GO:0006600) | 5.60520926 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 5.49608168 |
| 8 | fatty acid transmembrane transport (GO:1902001) | 5.31214278 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 5.11873470 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 5.07612747 |
| 11 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.00193374 |
| 12 | actin-myosin filament sliding (GO:0033275) | 4.89592231 |
| 13 | muscle filament sliding (GO:0030049) | 4.89592231 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.72730734 |
| 15 | response to muscle activity (GO:0014850) | 4.62664676 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.62400890 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.54341726 |
| 18 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.49796522 |
| 19 | branched-chain amino acid catabolic process (GO:0009083) | 4.49466338 |
| 20 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.47828724 |
| 21 | carnitine transmembrane transport (GO:1902603) | 4.43900697 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.42790972 |
| 23 | biotin metabolic process (GO:0006768) | 4.36337192 |
| 24 | regulation of sarcomere organization (GO:0060297) | 4.34232375 |
| 25 | response to inactivity (GO:0014854) | 4.32773124 |
| 26 | adult heart development (GO:0007512) | 4.29376452 |
| 27 | fatty acid oxidation (GO:0019395) | 4.26706622 |
| 28 | cardiac muscle contraction (GO:0060048) | 4.26343085 |
| 29 | fatty acid catabolic process (GO:0009062) | 4.25572148 |
| 30 | lipid oxidation (GO:0034440) | 4.19603794 |
| 31 | amino-acid betaine transport (GO:0015838) | 4.18882072 |
| 32 | carnitine transport (GO:0015879) | 4.18882072 |
| 33 | protein complex biogenesis (GO:0070271) | 4.15276895 |
| 34 | actin-mediated cell contraction (GO:0070252) | 4.13494502 |
| 35 | NADH metabolic process (GO:0006734) | 4.13353568 |
| 36 | valine metabolic process (GO:0006573) | 4.12257824 |
| 37 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.11739829 |
| 38 | branched-chain amino acid metabolic process (GO:0009081) | 4.10914434 |
| 39 | regulation of actin filament-based movement (GO:1903115) | 4.10662300 |
| 40 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.07392674 |
| 41 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.07392674 |
| 42 | NADH dehydrogenase complex assembly (GO:0010257) | 4.07392674 |
| 43 | 2-oxoglutarate metabolic process (GO:0006103) | 4.05478988 |
| 44 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.05205669 |
| 45 | skeletal muscle fiber development (GO:0048741) | 4.03620001 |
| 46 | glycogen catabolic process (GO:0005980) | 4.03315067 |
| 47 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.01630062 |
| 48 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.00388954 |
| 49 | regulation of cofactor metabolic process (GO:0051193) | 3.95405909 |
| 50 | regulation of coenzyme metabolic process (GO:0051196) | 3.95405909 |
| 51 | muscle contraction (GO:0006936) | 3.95170014 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 3.94579950 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.92254177 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.89050548 |
| 55 | myotube cell development (GO:0014904) | 3.87716635 |
| 56 | cardiac muscle cell development (GO:0055013) | 3.84431796 |
| 57 | heart process (GO:0003015) | 3.84068215 |
| 58 | heart contraction (GO:0060047) | 3.84068215 |
| 59 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.79310682 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.77941680 |
| 61 | actomyosin structure organization (GO:0031032) | 3.75409134 |
| 62 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.72622791 |
| 63 | cytochrome complex assembly (GO:0017004) | 3.72527926 |
| 64 | striated muscle contraction (GO:0006941) | 3.70149481 |
| 65 | glucan biosynthetic process (GO:0009250) | 3.70043861 |
| 66 | glycogen biosynthetic process (GO:0005978) | 3.70043861 |
| 67 | cardiac muscle hypertrophy (GO:0003300) | 3.69806372 |
| 68 | muscle fiber development (GO:0048747) | 3.68770958 |
| 69 | quinone biosynthetic process (GO:1901663) | 3.68708526 |
| 70 | ubiquinone biosynthetic process (GO:0006744) | 3.68708526 |
| 71 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.68141030 |
| 72 | glucan catabolic process (GO:0009251) | 3.67136624 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 3.64180309 |
| 74 | cardiac cell development (GO:0055006) | 3.60633362 |
| 75 | monocarboxylic acid catabolic process (GO:0072329) | 3.56901342 |
| 76 | carnitine metabolic process (GO:0009437) | 3.56448329 |
| 77 | regulation of striated muscle contraction (GO:0006942) | 3.56441608 |
| 78 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.55247131 |
| 79 | respiratory electron transport chain (GO:0022904) | 3.52065176 |
| 80 | behavioral response to nicotine (GO:0035095) | 3.51702789 |
| 81 | lysine metabolic process (GO:0006553) | 3.50821170 |
| 82 | lysine catabolic process (GO:0006554) | 3.50821170 |
| 83 | muscle system process (GO:0003012) | 3.50184184 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 3.47930956 |
| 85 | striated muscle hypertrophy (GO:0014897) | 3.47590415 |
| 86 | acetyl-CoA metabolic process (GO:0006084) | 3.46170644 |
| 87 | quaternary ammonium group transport (GO:0015697) | 3.44464146 |
| 88 | cellular polysaccharide catabolic process (GO:0044247) | 3.41771575 |
| 89 | electron transport chain (GO:0022900) | 3.39538327 |
| 90 | muscle tissue morphogenesis (GO:0060415) | 3.38936997 |
| 91 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.38881300 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.38558303 |
| 93 | daunorubicin metabolic process (GO:0044597) | 3.34403452 |
| 94 | polyketide metabolic process (GO:0030638) | 3.34403452 |
| 95 | doxorubicin metabolic process (GO:0044598) | 3.34403452 |
| 96 | positive regulation of fatty acid oxidation (GO:0046321) | 3.34212693 |
| 97 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.33215473 |
| 98 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.32542925 |
| 99 | skeletal muscle contraction (GO:0003009) | 3.28757674 |
| 100 | brown fat cell differentiation (GO:0050873) | 3.28531168 |
| 101 | muscle hypertrophy (GO:0014896) | 3.26910145 |
| 102 | glyoxylate metabolic process (GO:0046487) | 3.20986307 |
| 103 | regulation of triglyceride catabolic process (GO:0010896) | 3.19667936 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 3.18255070 |
| 105 | regulation of hexokinase activity (GO:1903299) | 3.16919407 |
| 106 | regulation of glucokinase activity (GO:0033131) | 3.16919407 |
| 107 | plasma membrane repair (GO:0001778) | 3.15654047 |
| 108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14398220 |
| 109 | succinate metabolic process (GO:0006105) | 3.14067578 |
| 110 | ubiquinone metabolic process (GO:0006743) | 3.14007759 |
| 111 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.13576999 |
| 112 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.13576999 |
| 113 | oxidative phosphorylation (GO:0006119) | 3.12559083 |
| 114 | ATP synthesis coupled proton transport (GO:0015986) | 3.10898164 |
| 115 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.10898164 |
| 116 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10828673 |
| 117 | positive regulation of lipid storage (GO:0010884) | 3.10669312 |
| 118 | gluconeogenesis (GO:0006094) | 3.09138871 |
| 119 | response to caffeine (GO:0031000) | 3.09099142 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08079569 |
| 121 | polysaccharide catabolic process (GO:0000272) | 3.08042622 |
| 122 | tricarboxylic acid metabolic process (GO:0072350) | 3.06975920 |
| 123 | adrenergic receptor signaling pathway (GO:0071875) | 3.06801968 |
| 124 | amino-acid betaine metabolic process (GO:0006577) | 3.06728124 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 3.03569142 |
| 126 | regulation of cardiac muscle contraction (GO:0055117) | 3.03103825 |
| 127 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.02545088 |
| 128 | base-excision repair, AP site formation (GO:0006285) | 3.01846349 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 3.00158897 |
| 130 | ketone body metabolic process (GO:1902224) | 2.99628724 |
| 131 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.98478569 |
| 132 | skeletal muscle adaptation (GO:0043501) | 2.97883337 |
| 133 | neuronal action potential propagation (GO:0019227) | 2.97743032 |
| 134 | positive regulation of heart rate (GO:0010460) | 2.96892804 |
| 135 | striated muscle cell development (GO:0055002) | 2.96031777 |
| 136 | striated muscle atrophy (GO:0014891) | 2.91411966 |
| 137 | iron-sulfur cluster assembly (GO:0016226) | 2.90553497 |
| 138 | metallo-sulfur cluster assembly (GO:0031163) | 2.90553497 |
| 139 | NAD metabolic process (GO:0019674) | 2.90311714 |
| 140 | skeletal muscle tissue development (GO:0007519) | 2.89601598 |
| 141 | AMP metabolic process (GO:0046033) | 2.89518945 |
| 142 | regulation of ATPase activity (GO:0043462) | 2.88353451 |
| 143 | regulation of ATP catabolic process (GO:1903289) | 2.88353451 |
| 144 | actin filament-based movement (GO:0030048) | 2.86474751 |
| 145 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.84525970 |
| 146 | positive regulation of mitochondrial fission (GO:0090141) | 2.83103092 |
| 147 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80396129 |
| 148 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.77909529 |
| 149 | muscle organ morphogenesis (GO:0048644) | 2.76774273 |
| 150 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75025797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.17175409 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.00273481 |
| 3 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.64777500 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.17838966 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00210884 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93697775 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91811119 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.80407509 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.64436995 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.63896108 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.59205116 |
| 12 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.57508688 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.52989908 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.52247421 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.51985936 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50168316 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.47702409 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.44935655 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44644140 |
| 20 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.38928851 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.29128205 |
| 22 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.28811639 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.28172656 |
| 24 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.24517893 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.23031231 |
| 26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.19300977 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.19300977 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13756158 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07806525 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07609518 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.02401586 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.00266170 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.99880718 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97880180 |
| 35 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.95727312 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.94081955 |
| 37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.84041469 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.82888116 |
| 39 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.82149268 |
| 40 | * P68_20966046_ChIP-Seq_HELA_Human | 1.81262300 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.80943111 |
| 42 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.73923179 |
| 43 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.71850947 |
| 44 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.70872535 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70704029 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.70375578 |
| 47 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.68015573 |
| 48 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.66851483 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.66801500 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62920515 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56802320 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56355236 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56069098 |
| 54 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.55645491 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.55407411 |
| 56 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.54774978 |
| 57 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.53908048 |
| 58 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.52099440 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52011044 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51372878 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.50715169 |
| 62 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.50442440 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50213992 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48697760 |
| 65 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.48461837 |
| 66 | ERA_21632823_ChIP-Seq_H3396_Human | 1.47851089 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.47832568 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46380849 |
| 69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.44505676 |
| 70 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43623976 |
| 71 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.42760637 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40784180 |
| 73 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.40243188 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39895355 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39816268 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38997474 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38264727 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35701300 |
| 79 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.34859797 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33940718 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32329335 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29870444 |
| 83 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.26892070 |
| 84 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.26869281 |
| 85 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.26570671 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26470235 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.24681727 |
| 88 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23589033 |
| 89 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.23017479 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.21343166 |
| 91 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21085860 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19524075 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19292483 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18848277 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18154916 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.16281868 |
| 97 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.16251836 |
| 98 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15186007 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 1.13612679 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12996223 |
| 101 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12158170 |
| 102 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.12066271 |
| 103 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11590092 |
| 104 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.11325338 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10786486 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09896555 |
| 107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09005405 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08244317 |
| 109 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08168419 |
| 110 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08150987 |
| 111 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07256668 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07012577 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06707933 |
| 114 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06668051 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06659132 |
| 116 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05711922 |
| 117 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.05644174 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04305015 |
| 119 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04018737 |
| 120 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03887918 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.03744468 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.03730157 |
| 123 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.02951501 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.02468214 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02309864 |
| 126 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01670897 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01473045 |
| 128 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.01371154 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00405867 |
| 130 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00139031 |
| 131 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00100600 |
| 132 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99531982 |
| 133 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99363770 |
| 134 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99299329 |
| 135 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98688327 |
| 136 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97551769 |
| 137 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97085430 |
| 138 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96787672 |
| 139 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.96120206 |
| 140 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.95847231 |
| 141 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95825365 |
| 142 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95353381 |
| 143 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95347165 |
| 144 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.95211971 |
| 145 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94983695 |
| 146 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94940703 |
| 147 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.94454244 |
| 148 | NCOR_22424771_ChIP-Seq_293T_Human | 0.91527378 |
| 149 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91508425 |
| 150 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91336996 |
| 151 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.91004714 |
| 152 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90488470 |
| 153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90244388 |
| 154 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.88903143 |
| 155 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87571150 |
| 156 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87135263 |
| 157 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86872576 |
| 158 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86695341 |
| 159 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86159405 |
| 160 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86095111 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85412847 |
| 162 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.84510227 |
| 163 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83915479 |
| 164 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82441913 |
| 165 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81857998 |
| 166 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80550314 |
| 167 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80546916 |
| 168 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.80455473 |
| 169 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.80147182 |
| 170 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79808649 |
| 171 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.78612292 |
| 172 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78436202 |
| 173 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78103884 |
| 174 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77607301 |
| 175 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77534474 |
| 176 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77020389 |
| 177 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.76500993 |
| 178 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75970879 |
| 179 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75871506 |
| 180 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75789251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.59808831 |
| 2 | MP0003646_muscle_fatigue | 6.03592741 |
| 3 | MP0005670_abnormal_white_adipose | 4.22449778 |
| 4 | MP0000751_myopathy | 4.07046899 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.74719312 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.54961573 |
| 7 | MP0000749_muscle_degeneration | 3.36898411 |
| 8 | MP0005330_cardiomyopathy | 3.17942830 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.01223261 |
| 10 | MP0004130_abnormal_muscle_cell | 2.90725641 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.44192081 |
| 12 | MP0003828_pulmonary_edema | 2.40153882 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.39301851 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.34208974 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.27169982 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.18376658 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.14800913 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.10154743 |
| 19 | MP0001544_abnormal_cardiovascular_syste | 2.06421371 |
| 20 | MP0005385_cardiovascular_system_phenoty | 2.06421371 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.02861058 |
| 22 | MP0004484_altered_response_of | 1.97727433 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.95807867 |
| 24 | MP0006138_congestive_heart_failure | 1.94541072 |
| 25 | MP0000750_abnormal_muscle_regeneration | 1.92749103 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.79619747 |
| 27 | MP0002269_muscular_atrophy | 1.72657223 |
| 28 | MP0005369_muscle_phenotype | 1.68185239 |
| 29 | MP0005365_abnormal_bile_salt | 1.66567939 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.60860980 |
| 31 | MP0005360_urolithiasis | 1.60790154 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.59245353 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.56426210 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.53973699 |
| 35 | MP0004510_myositis | 1.44835917 |
| 36 | MP0004085_abnormal_heartbeat | 1.39448479 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.39052567 |
| 38 | MP0002971_abnormal_brown_adipose | 1.38483678 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.38395095 |
| 40 | MP0003195_calcinosis | 1.35509538 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.34623775 |
| 42 | MP0005451_abnormal_body_composition | 1.33070667 |
| 43 | MP0002127_abnormal_cardiovascular_syste | 1.32554051 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.26813609 |
| 45 | MP0009697_abnormal_copulation | 1.25454654 |
| 46 | MP0000343_altered_response_to | 1.24201468 |
| 47 | MP0005535_abnormal_body_temperature | 1.23932027 |
| 48 | MP0005334_abnormal_fat_pad | 1.23799650 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.23468238 |
| 50 | MP0003724_increased_susceptibility_to | 1.21808296 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.21396639 |
| 52 | MP0005332_abnormal_amino_acid | 1.20852781 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.17526433 |
| 54 | MP0002822_catalepsy | 1.17473500 |
| 55 | MP0003252_abnormal_bile_duct | 1.15310827 |
| 56 | MP0000747_muscle_weakness | 1.15134136 |
| 57 | MP0001529_abnormal_vocalization | 1.14784098 |
| 58 | MP0001661_extended_life_span | 1.14659633 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.14542127 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.11567192 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.09894305 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.07888343 |
| 63 | MP0003941_abnormal_skin_development | 1.07624838 |
| 64 | MP0000566_synostosis | 1.07418880 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.05066527 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.03464546 |
| 67 | MP0001188_hyperpigmentation | 1.03013333 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 1.02732132 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.99865067 |
| 70 | MP0001764_abnormal_homeostasis | 0.98330828 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.96780902 |
| 72 | MP0009115_abnormal_fat_cell | 0.95167564 |
| 73 | MP0005083_abnormal_biliary_tract | 0.95081665 |
| 74 | MP0003186_abnormal_redox_activity | 0.94864781 |
| 75 | MP0004147_increased_porphyrin_level | 0.92605903 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.92040595 |
| 77 | MP0004142_abnormal_muscle_tone | 0.90483829 |
| 78 | MP0005266_abnormal_metabolism | 0.90347527 |
| 79 | MP0000733_abnormal_muscle_development | 0.90307015 |
| 80 | MP0005165_increased_susceptibility_to | 0.90208374 |
| 81 | MP0000003_abnormal_adipose_tissue | 0.89218091 |
| 82 | MP0002638_abnormal_pupillary_reflex | 0.89164290 |
| 83 | MP0003279_aneurysm | 0.87454171 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.86755156 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.86129745 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85601264 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.85533760 |
| 88 | MP0002132_abnormal_respiratory_system | 0.85458912 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.84848763 |
| 90 | MP0005171_absent_coat_pigmentation | 0.84183199 |
| 91 | MP0001984_abnormal_olfaction | 0.82565295 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 0.81793821 |
| 93 | MP0009764_decreased_sensitivity_to | 0.80834044 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.78493840 |
| 95 | MP0003136_yellow_coat_color | 0.77262171 |
| 96 | MP0004133_heterotaxia | 0.77235045 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.77119122 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.76750007 |
| 99 | MP0006276_abnormal_autonomic_nervous | 0.72909275 |
| 100 | MP0008995_early_reproductive_senescence | 0.71618604 |
| 101 | MP0004043_abnormal_pH_regulation | 0.71277050 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70016496 |
| 103 | MP0005647_abnormal_sex_gland | 0.69757956 |
| 104 | MP0000609_abnormal_liver_physiology | 0.68316862 |
| 105 | MP0005409_darkened_coat_color | 0.68063472 |
| 106 | MP0008872_abnormal_physiological_respon | 0.67262892 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.66381752 |
| 108 | MP0003011_delayed_dark_adaptation | 0.66253884 |
| 109 | MP0000266_abnormal_heart_morphology | 0.65348724 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.62957990 |
| 111 | MP0004924_abnormal_behavior | 0.62957990 |
| 112 | MP0002163_abnormal_gland_morphology | 0.62818851 |
| 113 | MP0005551_abnormal_eye_electrophysiolog | 0.62060721 |
| 114 | MP0001853_heart_inflammation | 0.61611319 |
| 115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.60328312 |
| 116 | MP0002970_abnormal_white_adipose | 0.60064743 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.59236878 |
| 118 | MP0001905_abnormal_dopamine_level | 0.58258600 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.57084839 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.56100488 |
| 121 | MP0008058_abnormal_DNA_repair | 0.55607791 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.55582714 |
| 123 | MP0005646_abnormal_pituitary_gland | 0.52477039 |
| 124 | MP0009046_muscle_twitch | 0.52077488 |
| 125 | MP0004742_abnormal_vestibular_system | 0.50230466 |
| 126 | MP0009763_increased_sensitivity_to | 0.50207435 |
| 127 | MP0004270_analgesia | 0.49127798 |
| 128 | MP0005448_abnormal_energy_balance | 0.47650530 |
| 129 | MP0005452_abnormal_adipose_tissue | 0.47369457 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.46916967 |
| 131 | MP0003953_abnormal_hormone_level | 0.44077319 |
| 132 | MP0009745_abnormal_behavioral_response | 0.43137980 |
| 133 | MP0004233_abnormal_muscle_weight | 0.42371467 |
| 134 | MP0002234_abnormal_pharynx_morphology | 0.42191085 |
| 135 | MP0002067_abnormal_sensory_capabilities | 0.41218397 |
| 136 | MP0005253_abnormal_eye_physiology | 0.41173453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.59082300 |
| 2 | Nemaline bodies (HP:0003798) | 8.42955049 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.21480013 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.88263870 |
| 5 | Sudden death (HP:0001699) | 5.58042124 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.33945208 |
| 7 | Myopathic facies (HP:0002058) | 5.18668820 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.10741638 |
| 9 | Myoglobinuria (HP:0002913) | 4.89521907 |
| 10 | Exercise-induced myalgia (HP:0003738) | 4.85160634 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.77457929 |
| 12 | Atrial fibrillation (HP:0005110) | 4.64174767 |
| 13 | Distal arthrogryposis (HP:0005684) | 4.52206540 |
| 14 | Lipoatrophy (HP:0100578) | 4.27310007 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.24248408 |
| 16 | Muscle fiber splitting (HP:0003555) | 4.23341935 |
| 17 | Supraventricular tachycardia (HP:0004755) | 4.06968548 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 4.06309820 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 3.98545845 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.96154027 |
| 21 | Supraventricular arrhythmia (HP:0005115) | 3.94854961 |
| 22 | Palpitations (HP:0001962) | 3.94501698 |
| 23 | Hyperglycinuria (HP:0003108) | 3.93360872 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.85985839 |
| 25 | Dilated cardiomyopathy (HP:0001644) | 3.85560263 |
| 26 | Rimmed vacuoles (HP:0003805) | 3.83111418 |
| 27 | Hepatic necrosis (HP:0002605) | 3.79467508 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.77728388 |
| 29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.75614962 |
| 30 | Subaortic stenosis (HP:0001682) | 3.75614962 |
| 31 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.72542663 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.72542663 |
| 33 | Round ear (HP:0100830) | 3.68287587 |
| 34 | Ulnar deviation of the wrist (HP:0003049) | 3.51124512 |
| 35 | Renal cortical cysts (HP:0000803) | 3.47068638 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 3.46105988 |
| 37 | Ketoacidosis (HP:0001993) | 3.40537698 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 3.36323516 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.33512575 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.29705498 |
| 41 | Increased muscle lipid content (HP:0009058) | 3.23004308 |
| 42 | Syncope (HP:0001279) | 3.21378223 |
| 43 | Hyporeflexia of lower limbs (HP:0002600) | 3.11570781 |
| 44 | EMG: myopathic abnormalities (HP:0003458) | 3.10086519 |
| 45 | Prolonged QT interval (HP:0001657) | 3.09333267 |
| 46 | Hepatocellular necrosis (HP:0001404) | 3.08389889 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07737018 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 3.07737018 |
| 49 | Ketosis (HP:0001946) | 3.04193032 |
| 50 | Heart block (HP:0012722) | 3.03893527 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.03813989 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 3.03813989 |
| 53 | Hyperalaninemia (HP:0003348) | 3.03813989 |
| 54 | Cerebral edema (HP:0002181) | 3.01209851 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.99576750 |
| 56 | Bundle branch block (HP:0011710) | 2.99305642 |
| 57 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.94956887 |
| 58 | Acute encephalopathy (HP:0006846) | 2.91665267 |
| 59 | Absent phalangeal crease (HP:0006109) | 2.90831006 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 2.89358592 |
| 61 | Increased connective tissue (HP:0009025) | 2.87887631 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.87675406 |
| 63 | Abnormal atrioventricular conduction (HP:0005150) | 2.87074173 |
| 64 | Testicular atrophy (HP:0000029) | 2.84968228 |
| 65 | Atrioventricular block (HP:0001678) | 2.84498882 |
| 66 | Lactic acidosis (HP:0003128) | 2.79883650 |
| 67 | EMG: neuropathic changes (HP:0003445) | 2.74902795 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.73082754 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.72758850 |
| 70 | Hyperammonemia (HP:0001987) | 2.69559483 |
| 71 | Increased CSF lactate (HP:0002490) | 2.68283261 |
| 72 | Increased intramyocellular lipid droplets (HP:0012240) | 2.64434198 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61153709 |
| 74 | Calcaneovalgus deformity (HP:0001848) | 2.59181745 |
| 75 | Ventricular arrhythmia (HP:0004308) | 2.57165293 |
| 76 | Frequent falls (HP:0002359) | 2.54592685 |
| 77 | Myotonia (HP:0002486) | 2.53161965 |
| 78 | Progressive muscle weakness (HP:0003323) | 2.52576676 |
| 79 | Deformed tarsal bones (HP:0008119) | 2.47977070 |
| 80 | Exercise intolerance (HP:0003546) | 2.47210104 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44756418 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.44729739 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43905659 |
| 84 | Nausea (HP:0002018) | 2.43883094 |
| 85 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.39474399 |
| 86 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.39474399 |
| 87 | Progressive macrocephaly (HP:0004481) | 2.38872236 |
| 88 | Malignant hyperthermia (HP:0002047) | 2.38479445 |
| 89 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.37659217 |
| 90 | Abnormal finger flexion creases (HP:0006143) | 2.34821958 |
| 91 | Muscle stiffness (HP:0003552) | 2.30665587 |
| 92 | Hyperglycinemia (HP:0002154) | 2.29197914 |
| 93 | Lethargy (HP:0001254) | 2.25885112 |
| 94 | Bulbar palsy (HP:0001283) | 2.25396775 |
| 95 | Metabolic acidosis (HP:0001942) | 2.23187278 |
| 96 | Abnormal EKG (HP:0003115) | 2.22672652 |
| 97 | Left ventricular hypertrophy (HP:0001712) | 2.22535953 |
| 98 | Difficulty running (HP:0009046) | 2.21928309 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 2.20561717 |
| 100 | Weak cry (HP:0001612) | 2.14192425 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 2.10022686 |
| 102 | Respiratory failure (HP:0002878) | 2.07621763 |
| 103 | Fetal akinesia sequence (HP:0001989) | 2.06390589 |
| 104 | Type 2 muscle fiber atrophy (HP:0003554) | 2.05791172 |
| 105 | Oligomenorrhea (HP:0000876) | 2.04946304 |
| 106 | Abnormality of urine glucose concentration (HP:0011016) | 2.04509063 |
| 107 | Glycosuria (HP:0003076) | 2.04509063 |
| 108 | Limb-girdle muscle atrophy (HP:0003797) | 2.01588723 |
| 109 | Increased serum lactate (HP:0002151) | 2.00720021 |
| 110 | Hypoalphalipoproteinemia (HP:0003233) | 1.99976047 |
| 111 | Palmoplantar keratoderma (HP:0000982) | 1.97578684 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.97274951 |
| 113 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.96103826 |
| 114 | Muscle fiber atrophy (HP:0100295) | 1.95840225 |
| 115 | Increased hepatocellular lipid droplets (HP:0006565) | 1.95423138 |
| 116 | Cerebral palsy (HP:0100021) | 1.94779288 |
| 117 | Vomiting (HP:0002013) | 1.94171823 |
| 118 | Hyperglycemia (HP:0003074) | 1.93031566 |
| 119 | Gowers sign (HP:0003391) | 1.92840996 |
| 120 | Hypoglycemic seizures (HP:0002173) | 1.92123891 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.87886206 |
| 122 | Generalized muscle weakness (HP:0003324) | 1.87671466 |
| 123 | Facial diplegia (HP:0001349) | 1.85579084 |
| 124 | Areflexia of lower limbs (HP:0002522) | 1.85413569 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.83509223 |
| 126 | Methylmalonic aciduria (HP:0012120) | 1.82037923 |
| 127 | Toxemia of pregnancy (HP:0100603) | 1.80547368 |
| 128 | Microvesicular hepatic steatosis (HP:0001414) | 1.78514092 |
| 129 | Neck muscle weakness (HP:0000467) | 1.78209919 |
| 130 | Duplicated collecting system (HP:0000081) | 1.78137881 |
| 131 | Fatigable weakness (HP:0003473) | 1.77465983 |
| 132 | Abnormality of the neuromuscular junction (HP:0003398) | 1.77465983 |
| 133 | Methylmalonic acidemia (HP:0002912) | 1.76532621 |
| 134 | Hyperkalemia (HP:0002153) | 1.66530374 |
| 135 | Waddling gait (HP:0002515) | 1.65744360 |
| 136 | Muscular dystrophy (HP:0003560) | 1.62093197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.78995050 |
| 2 | TTN | 3.69229512 |
| 3 | ZAK | 3.32487306 |
| 4 | INSRR | 3.30905240 |
| 5 | OBSCN | 3.21370073 |
| 6 | PHKG2 | 3.01700645 |
| 7 | PHKG1 | 3.01700645 |
| 8 | PINK1 | 3.00613418 |
| 9 | IRAK3 | 2.76750418 |
| 10 | MYLK | 2.69240816 |
| 11 | LMTK2 | 2.57337950 |
| 12 | TIE1 | 2.53608951 |
| 13 | PDK4 | 2.31048239 |
| 14 | PDK3 | 2.31048239 |
| 15 | MUSK | 2.27627222 |
| 16 | VRK2 | 2.14656365 |
| 17 | STK38L | 2.11479536 |
| 18 | GRK7 | 2.02859028 |
| 19 | PIK3CA | 1.91144538 |
| 20 | STK24 | 1.77964830 |
| 21 | TAOK3 | 1.76170906 |
| 22 | DMPK | 1.72161246 |
| 23 | NME1 | 1.65710917 |
| 24 | MAPKAPK3 | 1.62720338 |
| 25 | PDK2 | 1.59802073 |
| 26 | ADRBK2 | 1.48808511 |
| 27 | MAP4K1 | 1.31280847 |
| 28 | PKN1 | 1.31103167 |
| 29 | EIF2AK2 | 1.27944743 |
| 30 | STK16 | 1.27697394 |
| 31 | PRKAA2 | 1.27355870 |
| 32 | BMPR1B | 1.21576440 |
| 33 | FRK | 1.20874451 |
| 34 | MAP3K11 | 1.20110373 |
| 35 | MAP4K2 | 1.17115283 |
| 36 | STK4 | 1.13891374 |
| 37 | MAP2K4 | 1.12688693 |
| 38 | TXK | 1.12427889 |
| 39 | IRAK4 | 1.10767546 |
| 40 | CAMK1D | 1.07639017 |
| 41 | MAP3K14 | 1.02015434 |
| 42 | SGK2 | 0.99748836 |
| 43 | NEK1 | 0.99546487 |
| 44 | PRKAA1 | 0.95917814 |
| 45 | LIMK1 | 0.95775482 |
| 46 | PRPF4B | 0.94918861 |
| 47 | FLT3 | 0.93684973 |
| 48 | DAPK2 | 0.92436520 |
| 49 | MAPK12 | 0.86487327 |
| 50 | MAPK13 | 0.86379163 |
| 51 | CCNB1 | 0.84964578 |
| 52 | SIK1 | 0.84719251 |
| 53 | CASK | 0.83336736 |
| 54 | GRK1 | 0.82633452 |
| 55 | EPHA3 | 0.80651406 |
| 56 | CAMK2D | 0.79613524 |
| 57 | AKT3 | 0.78977035 |
| 58 | MARK1 | 0.77124886 |
| 59 | PKN2 | 0.76613004 |
| 60 | BMPR2 | 0.75764000 |
| 61 | SGK3 | 0.74967028 |
| 62 | TNIK | 0.72757179 |
| 63 | NLK | 0.72031841 |
| 64 | TRPM7 | 0.70403669 |
| 65 | PRKCE | 0.70097342 |
| 66 | EPHA2 | 0.69106170 |
| 67 | PRKD1 | 0.68939896 |
| 68 | PIK3CG | 0.68777351 |
| 69 | TAOK2 | 0.67853758 |
| 70 | WNK3 | 0.67489161 |
| 71 | CAMK4 | 0.66037108 |
| 72 | TEC | 0.65651960 |
| 73 | TLK1 | 0.65007851 |
| 74 | MAP2K7 | 0.63234110 |
| 75 | NEK2 | 0.63225634 |
| 76 | CDC42BPA | 0.62967411 |
| 77 | MAP3K7 | 0.62921166 |
| 78 | DYRK1B | 0.62240114 |
| 79 | EEF2K | 0.60229828 |
| 80 | MAP2K3 | 0.59555077 |
| 81 | RPS6KL1 | 0.58143330 |
| 82 | RPS6KC1 | 0.58143330 |
| 83 | MAP3K5 | 0.55500435 |
| 84 | CAMK1G | 0.54572884 |
| 85 | RPS6KA6 | 0.54534089 |
| 86 | TNK2 | 0.53608928 |
| 87 | MAP2K6 | 0.52563762 |
| 88 | MAPK7 | 0.51887002 |
| 89 | IRAK1 | 0.51333467 |
| 90 | TGFBR2 | 0.50756213 |
| 91 | IKBKE | 0.49986038 |
| 92 | DYRK2 | 0.48125180 |
| 93 | CAMK1 | 0.48062452 |
| 94 | SGK223 | 0.47933975 |
| 95 | SGK494 | 0.47933975 |
| 96 | PRKACA | 0.47691275 |
| 97 | MAPK11 | 0.46692141 |
| 98 | JAK1 | 0.46586335 |
| 99 | LATS1 | 0.46128099 |
| 100 | JAK3 | 0.44641708 |
| 101 | PRKACG | 0.44407160 |
| 102 | SRPK1 | 0.44112944 |
| 103 | VRK1 | 0.43108198 |
| 104 | KDR | 0.41426543 |
| 105 | SIK2 | 0.41191222 |
| 106 | NUAK1 | 0.40691881 |
| 107 | NEK9 | 0.40163809 |
| 108 | DYRK3 | 0.40003230 |
| 109 | WNK4 | 0.39510985 |
| 110 | IKBKB | 0.39472673 |
| 111 | CAMKK2 | 0.39418119 |
| 112 | MAPKAPK5 | 0.38626308 |
| 113 | IRAK2 | 0.38494514 |
| 114 | CDK8 | 0.38360655 |
| 115 | CDK19 | 0.38211984 |
| 116 | MAPK4 | 0.38094342 |
| 117 | FGFR4 | 0.37498693 |
| 118 | STK11 | 0.37246205 |
| 119 | SYK | 0.36296511 |
| 120 | TBK1 | 0.35135037 |
| 121 | SGK1 | 0.34622737 |
| 122 | PRKCQ | 0.34147589 |
| 123 | ROCK1 | 0.34049525 |
| 124 | STK38 | 0.34033140 |
| 125 | CAMK2A | 0.33958003 |
| 126 | YES1 | 0.32969066 |
| 127 | OXSR1 | 0.32439845 |
| 128 | ADRBK1 | 0.32379891 |
| 129 | ERBB3 | 0.32089253 |
| 130 | MAP3K13 | 0.31825988 |
| 131 | ERN1 | 0.31675547 |
| 132 | MAP3K6 | 0.31652949 |
| 133 | KIT | 0.30412633 |
| 134 | PRKG2 | 0.30389136 |
| 135 | CSNK1G3 | 0.30219434 |
| 136 | PRKG1 | 0.30110386 |
| 137 | CAMK2G | 0.29865121 |
| 138 | PAK3 | 0.29738082 |
| 139 | ATR | 0.29568830 |
| 140 | AKT2 | 0.29564729 |
| 141 | PRKACB | 0.28228843 |
| 142 | NEK6 | 0.28207066 |
| 143 | AURKA | 0.24067611 |
| 144 | MAP3K4 | 0.23905857 |
| 145 | ABL2 | 0.23428416 |
| 146 | MAPK15 | 0.23217563 |
| 147 | RPS6KA1 | 0.21987037 |
| 148 | TESK2 | 0.20212903 |
| 149 | RPS6KA5 | 0.19847579 |
| 150 | MAP2K1 | 0.18757167 |
| 151 | CAMK2B | 0.18705123 |
| 152 | RPS6KA3 | 0.16367887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.58486832 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.33395342 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.78270894 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.56986087 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.54368146 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.00419103 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.64808631 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53550058 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46470852 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.26575342 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.22246810 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22018061 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.20885905 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20157771 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.16115274 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.10670907 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.10209628 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.00548987 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98744040 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.95503794 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93021085 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.90075708 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.86714204 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84042796 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.73180655 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.63069275 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62600526 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42452188 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.39554719 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38378737 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.31977592 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.29619734 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.29057811 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.23772216 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22648648 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21781924 |
| 37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17312790 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17291098 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10079188 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07758024 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07591079 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07325200 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03848597 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03158021 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02533197 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00529194 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.99948437 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97584718 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 0.93067631 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 0.87974854 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.85674461 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85094177 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82615258 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79026403 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78042941 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77862066 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75557779 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75206927 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73576945 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73302852 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.73070218 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72527441 |
| 63 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71310094 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71172557 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66854540 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66597172 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65795909 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65413366 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.64935182 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64663607 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63190420 |
| 72 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62393618 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62081652 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61736146 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61377626 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60789631 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59903833 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59692409 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58762174 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58685992 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57546773 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56241019 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55197066 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55033920 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54620999 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54467356 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54363144 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52140990 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51730739 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51471132 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46416249 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45596236 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43592647 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41340170 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40444978 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40398591 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39202955 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38840922 |
| 99 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35211667 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32322792 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31661581 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30627749 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30317910 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.29688145 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28215056 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27782026 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27557045 |
| 108 | Insulin secretion_Homo sapiens_hsa04911 | 0.27289170 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.26010345 |
| 110 | Proteasome_Homo sapiens_hsa03050 | 0.25524268 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25125699 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23236916 |
| 113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22202268 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22119682 |
| 115 | Taste transduction_Homo sapiens_hsa04742 | 0.20752711 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20111372 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19786007 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18809537 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18465714 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.16866907 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.14963966 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.14729131 |
| 123 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.13681041 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | 0.13614767 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.13067216 |
| 126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.12826322 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12392049 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.10825533 |

